Prawo i regulacje · 07/12/2021

DEA Proposes Scheduling Methoxetamine (MXE) as a Schedule I Controlled Substance

The Drug Enforcement Administration (DEA) is proposing to place methoxetamine (MXE), a synthetic cathinone, in Schedule I of the Controlled Substances Act, which would impose strict regulatory controls and penalties on its handling and possession, in order to comply with international obligations under the 1971 Convention on Psychotropic Substances.